Radiopharm Theranostics has raised A$35 million through a private placement led by Lantheus Holdings, Inc. The funds will be used for the development of radiopharmaceutical products.
Amount Raised
A$35 Million
Round Type
Post-IPO Equity
SydneyBiotechnologyHealth CareMedicalInvestors
Description
Radiopharm Theranostics Limited has secured A$35 million in a private placement from international and Australian institutional investors, including Lantheus Holdings, Inc. Furthermore, the company is launching a Share Purchase Plan to raise an additional A$5 million for eligible shareholders. The funds from both initiatives will support the company’s development efforts. Chief Executive Officer Riccardo Canevari expressed satisfaction with the successful fundraising.
Who to call at Radiopharm Theranostics, and when
A new round usually means Radiopharm Theranostics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Radiopharm Theranostics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Radiopharm Theranostics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Radiopharm Theranostics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Radiopharm Theranostics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Radiopharm Theranostics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.